Home / TCF4 Knockout Cell Lines

TCF4 Knockout Cell Lines

Gene: TCF4

Official Full Name: transcription factor 4provided by HGNC

Gene Summary: This gene encodes transcription factor 4, a basic helix-loop-helix transcription factor. The encoded protein recognizes an Ephrussi-box ('E-box') binding site ('CANNTG') - a motif first identified in immunoglobulin enhancers. This gene is broadly expressed, and may play an important role in nervous system development. Defects in this gene are a cause of Pitt-Hopkins syndrome. In addition, an intronic CTG repeat normally numbering 10-37 repeat units can expand to >50 repeat units and cause Fuchs endothelial corneal dystrophy. Multiple alternatively spliced transcript variants that encode different proteins have been described. [provided by RefSeq, Jul 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO06492 TCF4 Knockout cell line (HEK293) Human TCF4 1:3~1:6 Negative Online Inquiry
KO06493 TCF4 Knockout cell line (A549) Human TCF4 1:3~1:4 Negative Online Inquiry

Background

TCF4 Gene Knockout Cell Lines are specifically engineered cellular models that lack the functional TCF4 gene, a critical regulator in various cellular processes, including cell proliferation, differentiation, and the Wnt signaling pathway. These cell lines are invaluable tools for researchers aiming to explore the molecular underpinnings of cancers, neurodevelopmental disorders, and other conditions influenced by aberrant TCF4 signaling.

The primary function of TCF4 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for studying the loss-of-function effects of TCF4. By utilizing CRISPR-Cas9 technology for precise genome editing, these cell lines allow researchers to investigate downstream effects on gene expression, signaling pathways, and cellular behavior in a targeted manner. This ability to dissect the complex regulatory networks associated with TCF4 impacts both basic biological research and applied clinical studies, enhancing our understanding of various pathologies linked to TCF4 malfunctions.

In research settings, the TCF4 Gene Knockout Cell Lines serve as valuable models for drug discovery and gene therapy initiatives, enabling scientists to screen for potential therapeutics that can compensate for the loss of TCF4 function. In clinical contexts, understanding TCF4 knockout impacts can inform the development of targeted treatments for diseases such as Wnt-related cancers or psychiatric disorders like schizophrenia.

Compared to traditional cell lines, these knockout models provide unique advantages, including the precise elimination of TCF4, which minimizes off-target effects common with pharmacological inhibitors. The specificity and reproducibility of these cell lines are instrumental for researchers seeking reliable and relevant data.

The value of TCF4 Gene Knockout Cell Lines extends beyond their experimental capabilities; they empower researchers and clinicians alike to probe deeper into TCF4-related pathways, facilitating novel insights that may lead to breakthrough therapies. Our company specializes in the development and optimization of cutting-edge biological products, ensuring that our offerings meet the highest standards of quality and scientific integrity to support the forefront of biomedical research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.